Literature DB >> 15889028

Measurement of baseline shoulder function in subjects receiving workers' compensation versus noncompensated subjects.

Peter I Sallay1, Patti J Hunker, Lindsey Brown.   

Abstract

The purpose of this study was to ascertain whether a measurable difference existed in normative scores for the American Shoulder and Elbow Surgeons (ASES) questionnaire between subjects who had an active workers' compensation claim (WC) with no known shoulder injury and subjects without a compensation claim (non-WC). Subjects with non-shoulder-related orthopaedic injuries were recruited from a suburban orthopaedic sports medicine clinic and an urban occupational medicine clinic. They were asked to complete a composite questionnaire that consisted of demographic information and the ASES questionnaire. There were no significant differences in the ASES scores between subject groups. There were significant differences between subject groups with regard to work hours (P = .0001), work demands (P = .0001), and tobacco use (P = .0001). Subject group was also significantly associated with education level (P = .0001), marital status (P = .0001), work demands (P = .0001), gender (P = .0001), and sports participation (P = .0314). The ASES score was significantly affected by marital status (P = .0476), sports participation (P = .0008), and age (P = .0129).

Entities:  

Mesh:

Year:  2005        PMID: 15889028     DOI: 10.1016/j.jse.2004.08.010

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  2 in total

Review 1.  Difference in outcome of shoulder surgery between workers' compensation and nonworkers' compensation populations.

Authors:  Paul Koljonen; Calvin Chong; Daniel Yip
Journal:  Int Orthop       Date:  2007-12-20       Impact factor: 3.075

2.  Do outcomes differ after rotator cuff repair for patients receiving workers' compensation?

Authors:  R Balyk; C Luciak-Corea; D Otto; D Baysal; L Beaupre
Journal:  Clin Orthop Relat Res       Date:  2008-09-11       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.